Annual report pursuant to Section 13 and 15(d)

WARRANTS - Schedule of fair value assumptions (Details)

v3.20.1
WARRANTS - Schedule of fair value assumptions (Details) - USD ($)
1 Months Ended
Sep. 16, 2019
Jul. 22, 2019
May 20, 2019
Oct. 22, 2018
Nov. 30, 2019
Class of Warrant or Right [Line Items]          
Exercise price         $ 0.25
Warrant [Member] | Warrants Granted, September 16, 2019 [Member]          
Class of Warrant or Right [Line Items]          
Risk free rate 1.69%        
Expected dividends 0.00%        
Expected volatility 150.00%        
Expected life 4 years 4 months 6 days        
Market price of the Company's common stock on date of grant $ 0.16        
Exercise price $ 0.25        
Warrant [Member] | Warrants Granted, July 22, 2019 [Member]          
Class of Warrant or Right [Line Items]          
Risk free rate   1.80%      
Expected dividends   0.00%      
Expected volatility   154.00%      
Expected life   4 years 6 months      
Market price of the Company's common stock on date of grant   $ 0.16      
Exercise price   $ 0.25      
Warrant [Member] | Warrants Granted, April 22, 2019 and May 20, 2019 [Member]          
Class of Warrant or Right [Line Items]          
Expected dividends     0.00%    
Expected life     4 years 6 months    
Market price of the Company's common stock on date of grant     $ 0.15    
Exercise price     $ 0.25    
Warrant [Member] | Warrants Granted, April 22, 2019 and May 20, 2019 [Member] | Minimum [Member]          
Class of Warrant or Right [Line Items]          
Risk free rate     2.21%    
Expected volatility     155.00%    
Warrant [Member] | Warrants Granted, April 22, 2019 and May 20, 2019 [Member] | Maximum [Member]          
Class of Warrant or Right [Line Items]          
Risk free rate     2.39%    
Expected volatility     156.00%    
Warrant [Member] | Warrants Granted, October 22, 2018 [Member]          
Class of Warrant or Right [Line Items]          
Risk free rate       3.05%  
Expected dividends       0.00%  
Expected volatility       159.00%  
Expected life       5 years  
Market price of the Company's common stock on date of grant       $ 0.14  
Exercise price       $ 0.25